From: Risk factors associated with acute kidney injury in a cohort of hospitalized patients with COVID-19
Variable | Adjusted OR | 95% CI |
---|---|---|
Sex | 2.28 | 1.73—2.99 |
Age | 1.02 | 1.01—1.03 |
Overweight or obesity | 1.31 | 0.98—1.75 |
History of HBP | 6.51 | 2.10—20.20 |
History of CKD | 3.61 | 2.03—6.42 |
Previous Treatment with statins | 0.57 | 0.38—0.85 |
Higher qSOFA score | 1.4 | 1.14—1.71 |
Lower platelet count at admission | 1.01 | 0.99—1.02 |
Higher CRP at admission | 1 | 0.99—1.01 |
Higher D-dimer at admission | 1 | 0.99—1.01 |
Treatment with vancomycin | 1.57 | 1.05—2.37 |
Treatment with Piperacillin tazobactam | 1.67 | 1.20—2.31 |
Treatment with Propofol | 1.45 | 0.94—2.24 |
Vasopressor support | 2.39 | 1.53—3.74 |
Interaction # 2a | 1.3 | 1.05—1.61 |
Interaction # 3b | 0.36 | 0.14—0.94 |